Data from The BMJ - Curated by EPG Health - Date added 09 March 2018

 

A study published by the BMJ reports a possible association between intake of highly processed “ultra-processed” food in the diet and cancer.

Further exploration is needed, but these results suggest that the rapidly increasing consumption of ultra-processed foods “may drive an increasing burden of cancer in the next decades” warn the researchers.

Ultra-processed foods include:

  • Packaged baked goods and snacks
  • Fizzy drinks
  • Sugary cereals
  • Ready meals
  • Reconstituted meat products

These products are thought to account for up to 50% of total daily energy intake in several developed countries.

A few studies have linked ultra-processed foods to higher risks of obesity, high blood pressure and cholesterol levels. But firm evidence linking intake to risk of disease is still scarce.

A team of researchers based in France and Brazil, set out to evaluate potential associations between ultra-processed intake and risk of overall cancer, as well as that of breast, prostate and bowel cancers.

Their findings are based on 104,980 health French adults (22% men; 78% women) with an average age of 43 years who completed at least two 24-hour online dietary questionnaires, designed to measure usual intake of 3,300 different food items.

Foods were grouped according to degree of processing and cases of cancer were identified from participants’ declarations validated by medical records and national databases over an average of five years.

Several well-known risk factors for cancer, such as age, educational level, family history of cancer, smoking status and physical activity levels, were considered.

The results show that a 10% increase in proportion of ultra-processed foods in the diet was associated with increases of 12% in the risk of overall cancer and 11% in the risk of breast cancer.  No significant association was found for prostate and colorectal cancers.

Further testing found no significant association between less processed foods (such as canned vegetables, cheeses and freshly made unpackaged bread) and risk of cancer, while consumption of fresh or minimally processed foods (fruits, vegetables, pulses, rice, pasta, eggs, meat, fish and milk) was associated with lower risks of overall cancer and breast cancer.

This is a firm conclusion can be drawn about cause and effect, and the researchers point to some limitations. For example, they cannot rule out some misclassification of foods or guarantee detection of every new cancer case. Nevertheless, the study sample was large and they were able to adjust for a range of potentially influential factors.

“To our knowledge, this study is the first to investigate and highlight an increase in the risk of overall – and specifically breast – cancer associated with ultra–processed food intake,” write the authors.

They stress that further work is needed to better understand the effects of the various stages of processing, but suggest policies targeting product reformulation, taxation and marketing restrictions on ultra-processed products and promotion of fresh or minimally processed foods may contribute to cancer prevention.

In a linked editorial, Martin Lajous and Adriana Monge based at the National Institute of Public Health in Mexico, say this study provides “an initial insight into a possible link between ultra-processed foods and cancer” but “we are a long way from understanding the full implications of food processing for health and wellbeing.”

They point to several challenges, such as identifying the precise elements in ultra–processed foods that could lead to cancer, and the potential impact of other unmeasured factors on the results.

As such, they conclude: “Care should be taken to transmit the strengths and limitations of this latest analysis to the general public and to increase the public’s understanding of the complexity associated with nutritional research in free living populations.”

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Load more

Related Content